Acumen Pharmaceuticals, Inc. Other Current Liabilities
Acumen Pharmaceuticals, Inc. (ABOS) had Other Current Liabilities of $201.00 thousand as of 2024-09-30, per its 10-Q filed 2024-11-12.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:OtherLiabilitiesCurrent · last filed 2024-11-12
- 2024-09-30: Other Liabilities, Current $201.00K.
- 2024-06-30: Other Liabilities, Current $149.00K.
- 2024-03-31: Other Liabilities, Current $481.00K.
- 2023-12-31: Other Liabilities, Current $212.00K.
| Period end | Other Liabilities, Current |
|---|---|
| 2024-09-30 | $201.00K 10-Q · filed 2024-11-12 |
| 2024-06-30 | $149.00K 10-Q · filed 2024-08-13 |
| 2024-03-31 | $481.00K 10-Q · filed 2024-05-14 |
| 2023-12-31 | $212.00K 10-Q · filed 2024-11-12 |
| 2023-09-30 | $81.00K 10-Q · filed 2023-11-13 |
| 2023-06-30 | $20.00K 10-Q · filed 2023-08-08 |
| 2023-03-31 | $94.00K 10-Q · filed 2023-05-09 |
| 2022-12-31 | $131.00K 10-K · filed 2024-03-26 |
| 2021-12-31 | $204.00K 10-K · filed 2023-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |